TY  - CONF

T1  - ZOLEDRONIC ACID (ZOL) REDUCES THE INCIDENCE OF SKELETAL-RELATED EVENT (SRES) AND MAY IMPROVE SURVIVAL IN PATIENTS WITH BONE METASTASES (METS) FROM RENAL CELL CARCINOMA (RCC): A RETROSPECTIVE INTEGRATED ANALYSIS

JO  - ANNALS OF ONCOLOGY

PY  - 2010/10/01

AU  - Michaelson D

AU  - Kpamegan EE

AU  - Perez JR

AU  - Brown J

ED  - 

VL  - 21

SP  - 287

EP  - 287

Y2  - 2024/12/21

ER  -